Table 4 Comparison in cancer cachexia between male and female patients

Ages (years)

65.32 ± 1.24

62.83 ± 2.42

0.313

BMI (kg/m²)

22.26 ± 0.47

21.65 ± 0.67

0.461

HB (g/L)

115.6 ± 3.92

103.8 ± 3.99

0.067

WBC (10^9/L)

6.13 ± 0.31

5.92 ± 0.40

0.697

PLT (10^9/L)

259.1 ± 14.07

271.1 ± 21.73

0.637

LY (10^9/L)

1.40 ± 0.08

1.55 ± 0.09

0.295

TP (g/L)

63.15 ± 0.88

65.52 ± 1.72

0.179

ALB (g/L)

39.31 ± 0.66

38.81 ± 1.08

0.686

PA (g/L)

0.186 ± 0.008

0.178 ± 0.011

0.557

TC (mmol/L)

3.84 ± 0.12

4.13 ± 0.18

0.191

TG (mmol/L)

1.216 ± 0.07

1.241 ± 0.14

0.858

ApoA (g/l)

202.1 ± 25.81

246.2 ± 51.42

0.395

ApoB (g/l)

0.84 ± 0.04

0.87 ± 0.05

0.648

ApoE (g/l)

34.64 ± 1.49

41.38 ± 2.57

0.019

FFA (pg/ml)

0.43 ± 0.03

0.56 ± 0.06

0.029

IL-6 (pg/ml)

7.47 ± 1.05

7.55 ± 1.25

0.961

TNF-α (pg/ml)

7.65 ± 0.42

8.74 ± 0.71

0.171

(I + II) TNM stage no. (%)

16 (32.0%)

8 (33.3%)

0.909